Skip to content
Search for:
회사소개
개요
연혁
경영진
윤리경영
제휴 영역
찾아오시는 길
핵심기술
NexP™ 지속형 기술
NexMab™ ADC기술
Hybrozyme™ 기술
바이오시밀러
기술적 성과
파이프라인
Overview
Project
ALT-P1
Project
ALT-P7
ALT-Q5
Project
ALT-L9
ALT-L2
ESG
ESG 경영
소개
ESG경영목표
ESG정책/가이드라인
Environmental
환경경영
안전보건경영
Social
인권경영소개
인권헌장
인권상담센터
인권상담 신청게시판
Governance
이사회
감사기구
준법경영
윤리헌장
IR
뉴스
보고서
공고
인재채용
알테오젠 인재상
채용공고
로그인
한국어
Loading...
News
alteogen
2018-04-27T13:47:37+09:00
News
Reports
Notices
News
Number
Title
Author
Date
Notice
Alteogen announces amendment to license agreement with MSD.
alteogen
|
2024.02.24
|
Votes 0
|
Views 847
alteogen
2024.02.24
Notice
Alteogen's Tergase® (Novel Recombinant Human Hyaluronidase Injection) Shows Excellent Immunogenicity Profile
alteogen
|
2023.09.06
|
Votes 0
|
Views 1488
alteogen
2023.09.06
Notice
Hyaluronidase : A new way to be excluded from drug price negotiations under IRA
alteogen
|
2023.08.01
|
Votes 0
|
Views 1671
alteogen
2023.08.01
Notice
Alteogen Enters Into an Exclusive License Agreement to Develop and Commercialize Biosimilar Products
alteogen
|
2023.01.06
|
Votes 0
|
Views 3498
alteogen
2023.01.06
Notice
Alteogen Announces Completion of Phase 1 Clinical Trial of Aflibercept Biosimilar in Wet AMD Patients
alteogen
|
2023.01.06
|
Votes 0
|
Views 2153
alteogen
2023.01.06
Notice
Alteogen Enters Into an Exclusive License Agreement With Intas to Develop and Commercialize Two Products
alteogen
|
2023.01.06
|
Votes 0
|
Views 1917
alteogen
2023.01.06
Notice
Alteogen Enters into a Global License Agreement with a Top Ten Pharmaceutical Company for Use of Its Hybrozyme™ Technology
alteogen
|
2023.01.06
|
Votes 0
|
Views 1952
alteogen
2023.01.06
Notice
Alteogen Enters into a Non-exclusive License Agreement with a Global Pharmaceutical Company for Use of Its Hybrozyme™Technology
alteogen
|
2023.01.06
|
Votes 0
|
Views 1680
alteogen
2023.01.06
9
24 AUG 2016 Human Phase1 Clinical Data of ALT-P1 (hGH-NexP) by Healthy Korean Males
alteogen
|
2018.05.28
|
Votes 0
|
Views 1361
alteogen
2018.05.28
8
2 MAR 2016 | Alteogen set to start phase I testing for Herceptin biosimilar
alteogen
|
2018.05.28
|
Votes 0
|
Views 1384
alteogen
2018.05.28
7
12 OCT 2015 | Alteogen inks deal with 3Sbio for ADC targeting HER2
alteogen
|
2018.05.28
|
Votes 0
|
Views 1387
alteogen
2018.05.28
6
13 JUL 2015 | The patent for long-acting recombinant Alpha-1 Antitrypsin (A1AT)
alteogen
|
2018.05.28
|
Votes 0
|
Views 1365
alteogen
2018.05.28
5
30 MAR 2015 | The project with KISSEI has been progressing steadily
alteogen
|
2018.05.28
|
Votes 0
|
Views 1255
alteogen
2018.05.28
4
12 DEC 2014 | ALTEOGEN is listed on KOSDAQ
alteogen
|
2018.05.28
|
Votes 0
|
Views 1197
alteogen
2018.05.28
3
03 DEC 2014 | NexP™ fusion technology patent registry in EU
alteogen
|
2018.05.28
|
Votes 0
|
Views 1270
alteogen
2018.05.28
2
18 AUG 2014 | NexP™ fusion technology patent registry in China
alteogen
|
2018.05.28
|
Votes 0
|
Views 1185
alteogen
2018.05.28
1
12 FEB 2014 | ALTEOGEN starts collaboration in mAb biosimilar with KISSEI Pharma.
alteogen
|
2018.05.28
|
Votes 0
|
Views 1360
alteogen
2018.05.28
First
«
1
2
3
All
Title
Content
Author
Search
Go to Top